Icon

TWYNSTA (nda022401)- (EQ 5MG BASE;40MG,EQ 10MG BASE;40MG,EQ 5MG BASE;80MG,EQ 10MG BASE;80MG)

AMLODIPINE BESYLATE; TELMISARTAN BOEHRINGER INGELHEIM
EQ 5MG BASE;40MG,EQ 10MG BASE;40MG,EQ 5MG BASE;80MG,EQ 10MG BASE;80MG
No Yes
2014-Jan-07 Expired
None None
None No
TWYNSTA is an angiotensin II receptor blocker (ARB) and a dihydropyridine calcium channel blocker (DHP-CCB) combination product indicated for the treatment of hypertension alone or with other antihypertensive agents to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. • TWYNSTA tablets are indicated as initial therapy in patients likely to need multiple antihypertensive agents to achieve their blood pressure goals.
3 0 3
Total Other Developers 5
Drugs with Suitability No
EQ 5MG BASE;40MG ** ** - - 2
EQ 10MG BASE;40MG ** ** - - 2
EQ 5MG BASE;80MG ** ** - - 2
EQ 10MG BASE;80MG ** ** - - 2
NDA Sales Available Total Generic Sales Available
No 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** *** ***** ******* *********** **** **. **-*, ***** *-*, ***** ********** ****, *****, ********, *** ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********-******* *******, ******, ******-****, ****. *******, ******, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.